Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
127.70
-0.87 (-0.68%)
Jul 9, 2026, 4:00 PM EDT - Market closed

Mirum Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Mirum Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $146.5. The average 1-year stock price forecast is 14.72% higher than the current stock price, while the lowest is $125 (-2.11%) and the highest is $185 (+44.87%).

Price Target: $146.5 (+14.72%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$125$146.5$145$185
Change-2.11%+14.72%+13.55%+44.87%

Analyst Ratings

The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy88891010
Buy333444
Hold000000
Sell000000
Strong Sell000000
Total111111131414

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Maintains
$142$148
BuyMaintains$142$148+15.90%Jul 7, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$115$125
BuyMaintains$115$125-2.11%Jul 2, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$150
BuyMaintains$150+17.46%Jun 15, 2026
Citi
Citi
Buy
Maintains
$145
BuyMaintains$145+13.55%Jun 15, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$185
BuyReiterates$185+44.87%Jun 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
675.29M
from 521.31M
Increased by 29.54%
Revenue Next Year
815.15M
from 675.29M
Increased by 20.71%
EPS This Year
-14.24
from -0.47
EPS Next Year
-0.09
from -14.24
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
19.14M77.06M186.37M336.89M521.31M675.29M
Revenue Growth
-302.67%141.85%80.76%54.74%29.54%
Gross Profit
17.24M64.69M139.34M255.25M421.07M539.56M
Gross Margin
90.06%83.94%74.76%75.77%80.77%79.90%
Operating Income
-173.41M-131.22M-109.15M-87.61M-22.14M-881.63M
Net Income
-83.99M-135.67M-163.42M-87.94M-23.36M-910.66M
EPS
-----0.47-14.24
Free Cash Flow
-96.18M-68.57M-91.35M16.67M98.56M-527.50M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High683.3M
Avg675.3M
Low669.0M

Revenue Growth

Revenue Growth202620272028
High
31.1%
Avg
29.5%
Low
28.3%

EPS Forecast

EPS202620272028
High-14.24
Avg-14.24
Low-14.24

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-